<DOC>
	<DOCNO>NCT00760461</DOCNO>
	<brief_summary>The primary objective study prescribe oral domperidone patient gastroparesis fail suffered adverse effect standard medical therapy .</brief_summary>
	<brief_title>Domperidone Refractory Gastroparesis</brief_title>
	<detailed_description />
	<mesh_term>Gastroparesis</mesh_term>
	<mesh_term>Domperidone</mesh_term>
	<criteria>Male female Age 18 old Symptoms manifestation secondary motility disorder upper GI tract . These include gastroparesis , functional dyspepsia , gastroesophageal reflux disease refractory standard therapy . Patients must comprehensive evaluation eliminate cause symptom . This include history physical examination . A recent ( within 3 year ) evaluation upper GI tract either upper endoscopy upper GI radiographic series . Baseline blood test suggest electrolyte , magnesium , prolactin level . Patient sign informed consent administration domperidone inform patient potential adverse event include : Increased prolactin level Breast change Extrapyramidal side effect Cardiac arrhythmia include QT prolongation ( increase risk drug list appendix ) History , current , arrhythmias include ventricular tachycardia , ventricular fibrillation Torsade des Pointes . Patients minor form ectopy ( PACs ) necessarily exclude . Clinically significant bradycardia , sinus node dysfunction , heart block . Prolonged QTc ( QTc &gt; 450 millisecond male , QTc &gt; 470 millisecond female ) Clinically significant electrolyte disorder . These include significant hypokalemia , hyperkalemia , hypomagnesemia , hypermagnesemia correct treatment electrolyte abnormality . Gastrointestinal hemorrhage obstruction . Presence prolactinoma ( prolactinreleasing pituitary tumor ) . Pregnant breast feeding female . Known allergy domperidone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>